Correlation between lung function and exhaled breath condensate biomarkers of inflammation in pulmonary diseases

T. Anokhina, E. Anaev, V. Apyari, A. Karyakin, A. Chuchalin (Moscow, Russian Federation)

Source: Annual Congress 2009 - Lung function in adults and children
Session: Lung function in adults and children
Session type: Oral Presentation
Number: 391
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Anokhina, E. Anaev, V. Apyari, A. Karyakin, A. Chuchalin (Moscow, Russian Federation). Correlation between lung function and exhaled breath condensate biomarkers of inflammation in pulmonary diseases. Eur Respir J 2009; 34: Suppl. 53, 391

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Markers of airway diseases in exhaled breath condensate and their clinical value
Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases
Year: 2013


Relationship between acidity of exhaled breath condensate, lung function and airway inflammation in asthmatic children
Source: Annual Congress 2007 - Assessing asthma severity and control in children
Year: 2007


Structures of an exhaled breath condensate in lung diseases
Source: Eur Respir J 2005; 26: Suppl. 49, 525s
Year: 2005

Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate
Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation
Year: 2008


The relationship between CT assessed lung damage, and inflammatory markers in exhaled breath condensate of cystic fibrosis patients
Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know?
Year: 2007


NO metabolites in exhaled breath condensate in cystic fibrosis patients: correlation with pulmonary function, nutritional status and systemic inflammation
Source: Eur Respir J 2006; 28: Suppl. 50, 715s
Year: 2006

Nitrite concentration in exhaled breath condensate correlates with markers of lung overdistension in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 317s
Year: 2004

Myeloperoxidase in exhaled breath condensate reflects the status of lung parenchyma during the exacerbation of chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 54s
Year: 2005

Exhaled breath condensate biomarkers in COPD
Source: Eur Respir J 2008; 32: 472-486
Year: 2008



Inflammatory markers in the exhaled breath condensate from patients with pulmonary sarcoidosis: comparison with BALF
Source: Eur Respir J 2006; 28: Suppl. 50, 353s
Year: 2006

Inflammatory markers in exhaled breath condensate of two COPD phenotypes
Source: Eur Respir J 2005; 26: Suppl. 49, 260s
Year: 2005

Relationship of inflamamatory markers in blood and exhaled breath condensate in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 283s
Year: 2006

The clinical significance of growth factors measurement in exhaled breath condensates (EBC) among patients with interstitial lung diseases
Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Year: 2010


MicroRNA-26a expression in exhaled breath condensate correlates with pulmonary exacerbation in cystic fibrosis
Source: Virtual Congress 2020 – Intercellular communication in tissue remodelling of chronic lung diseases
Year: 2020


Inflammatory markers in exhaled breath condensate in bronchiectasis
Source: Eur Respir J 2004; 24: Suppl. 48, 707s
Year: 2004